Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transformer-2 protein homolog beta (TRA2B) is a sequence-specific, serine/arginine-rich RNA-binding protein that functions primarily as a splicing factor in the nucleus, regulating alternative splicing and pre-mRNA processing. It can both activate and suppress exon inclusion, and plays a crucial role in modulating the splicing of target transcripts such as SMN2 and MAPT/Tau. TRA2B dysregulation has been implicated in diseases including tauopathies, epilepsy, and various cancers[1][2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transformer-2 protein homolog beta (TRA2B).